| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 21,811 | 22,766 | 18,263 | 23,697 | | Cost of Revenue | (28,704) | 14,806 | 13,898 | 14,824 | | | Gross Profit | 50,515 | 7,960 | 4,365 | 8,873 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 45,878 | 2,057 | 1,902 | 1,435 | | Non Recurring | 79 | (97) | 31,818 | 270 | | Others | 923 | 974 | 1,000 | 1,037 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,648 | 5,026 | (30,355) | 6,131 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (954) | 511 | (346) | (6,706) | | Earnings Before Interest And Taxes | 2,681 | 5,537 | (30,701) | (575) | | Interest Expense | 3,070 | 2,327 | 1,760 | 2,900 | | Income Before Tax | (389) | 3,210 | (32,461) | (3,475) | | Income Tax Expense | 53 | 39 | 46 | 71,902 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (442) | 3,171 | (32,507) | (75,377) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 9 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (442) | 3,171 | (32,507) | (75,368) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($442) | $3,171 | ($32,507) | ($75,368) |
|
0.03% Nasdaq 
0.02 (8.70%) 
Income Statement
